HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Oliver Weigert Selected Research
Oliver Weigert Research Topics
Disease
14
Lymphoma (Lymphomas)
05/2024 - 08/2006
13
Neoplasms (Cancer)
05/2024 - 08/2006
8
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 01/2006
7
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2024 - 08/2006
4
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2023 - 10/2008
4
B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 08/2012
3
COVID-19
02/2023 - 07/2021
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 02/2012
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 08/2012
2
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 10/2017
2
Inflammation (Inflammations)
12/2021 - 10/2018
2
Neutropenia
12/2021 - 01/2021
2
Disease Progression
01/2021 - 05/2009
1
Thrombocytopenia (Thrombopenia)
02/2023
1
Persistent Infection
01/2022
1
Severe Acute Respiratory Syndrome
01/2022
1
Infections
01/2022
1
cell-associated neurotoxicity
12/2021
1
Cytokine Release Syndrome
12/2021
1
Clinical Deterioration
07/2021
1
Septic Shock (Toxic Shock Syndrome)
01/2021
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1
Leukemia
10/2012
1
B-Cell Leukemia (Leukemia, B Cell)
10/2012
1
Breast Neoplasms (Breast Cancer)
08/2012
1
Lung Neoplasms (Lung Cancer)
08/2012
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2012
1
Genetic Translocation (Chromosomal Translocation)
12/2009
Drug/Important Bio-Agent (IBA)
5
Rituximab (Mabthera)
FDA Link
04/2024 - 01/2006
4
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2012
3
Bortezomib (Velcade)
FDA Link
04/2024 - 05/2009
3
Antibodies
IBA
01/2022 - 07/2021
3
Cytokines
IBA
12/2021 - 10/2018
3
Antigens
IBA
01/2020 - 01/2017
3
Vincristine (Oncovin)
FDA Link
Generic
09/2015 - 10/2008
2
Cytarabine (Cytosar-U)
FDA Link
Generic
04/2024 - 05/2009
2
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
02/2024 - 01/2022
2
Inosine Triphosphate (ITP)
IBA
02/2023 - 05/2010
2
Complement System Proteins (Complement)
IBA
11/2022 - 07/2021
2
axicabtagene ciloleucel
IBA
12/2021 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
12/2021 - 11/2018
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
07/2021 - 01/2021
2
Cyclin D1
IBA
10/2017 - 12/2009
2
Paraffin
IBA
01/2016 - 01/2013
2
Cytokine Receptors (Cytokine Receptor)
IBA
10/2012 - 02/2012
2
Monoclonal Antibodies
IBA
08/2006 - 01/2006
1
Dexamethasone (Maxidex)
FDA Link
Generic
04/2024
1
Vaccines
IBA
02/2023
1
BNT162 Vaccine
IBA
02/2023
1
Messenger RNA (mRNA)
IBA
02/2023
1
COVID-19 Vaccines
IBA
02/2023
1
Circulating Tumor DNA
IBA
11/2022
1
blinatumomab
IBA
01/2022
1
Leukocyte Immunoglobulin-like Receptor B1
IBA
01/2022
1
magrolimab
IBA
01/2022
1
Immunoglobulins (Immunoglobulin)
IBA
01/2022
1
cytidylyl-(3'-5')-cytidine (CpC)
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Interleukin-4 (Interleukin 4)
IBA
01/2022
1
C-Reactive Protein
IBA
12/2021
1
Hemoglobins (Hemoglobin)
IBA
12/2021
1
tisagenlecleucel
IBA
12/2021
1
Ferritins (Ferritin)
IBA
12/2021
1
Interferons
IBA
07/2021
1
Micafungin (FK463)
FDA Link
01/2021
1
Histone Acetyltransferases (Histone Acetyltransferase)
IBA
01/2020
1
cathepsin S
IBA
01/2020
1
Ligands
IBA
12/2019
1
Chemokines
IBA
10/2018
1
Agammaglobulinaemia Tyrosine Kinase
IBA
11/2016
1
ibrutinib
IBA
11/2016
1
Formaldehyde (Formol)
FDA Link
01/2016
1
Prednisone (Sone)
FDA Link
Generic
09/2015
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2015
1
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2015
1
DNA (Deoxyribonucleic Acid)
IBA
09/2015
1
GTP-Binding Proteins (G-Protein)
IBA
01/2015
1
bcr-abl Fusion Proteins
IBA
01/2015
1
Phosphotransferases (Kinase)
IBA
01/2015
1
Oncogene Proteins (Oncogene Protein)
IBA
10/2012
1
Antigen Receptors (Antigen Receptor)
IBA
09/2012
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
08/2012
1
ABT-737
IBA
08/2012
1
Enzymes
IBA
08/2012
1
Proteasome Inhibitors
IBA
06/2012
1
ATP dependent 26S protease (26S proteasome)
IBA
06/2012
1
Janus Kinase 2
IBA
02/2012
1
Autoantibodies
IBA
05/2010
1
Yttrium-90
IBA
08/2006
1
CD20 Antigens
IBA
08/2006
1
ibritumomab tiuxetan (Zevalin)
FDA Link
08/2006
Therapy/Procedure
10
Therapeutics
05/2024 - 01/2006
6
Drug Therapy (Chemotherapy)
05/2024 - 01/2006
4
Stem Cell Transplantation
01/2024 - 09/2006
4
Salvage Therapy
01/2020 - 09/2006
1
Precision Medicine
11/2022
1
Transplantation
01/2015
1
Aftercare (After-Treatment)
08/2012
1
Cell Transplantation
01/2012
1
Homologous Transplantation
01/2012